We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Virus Diagnosis Device Delivers Lab-Quality Results within Three Minutes

By LabMedica International staff writers
Posted on 03 Nov 2023

Researchers have developed a device capable of delivering lab-grade viral diagnostic results in just three minutes, offering a rapid and economical solution for detecting COVID-19 from nasal swabs. More...

This technology, according to its developers, is versatile enough to be modified for identifying various pathogens, such as bacteria, and potentially even cancer.

The prototype LoCKAmp device developed by engineers at the University of Bath (Bath, UK) uses advanced 'lab on a chip' technology. The device operates by quickly releasing and amplifying genetic material from a nasal swab sample and facilitating a chemical reaction that produces a result that can be viewed through a smartphone application. The LoCKAmp device differs from the common lateral flow tests used throughout the pandemic by employing the same genetic detection methods previously reserved for laboratory-grade PCR (polymerase chain reaction) tests, delivering rapid lab-level testing to the public for the first time. A key feature of the LoCKAmp is its rapid result time, clocking in at three minutes, making it the fastest COVID-19 test reported so far.

Built using readily available parts and mass-produced circuit boards, the LoCKAmp prototype device can be manufactured quickly and cost-effectively on a large scale. This presents an efficient new tool for healthcare providers and public health authorities globally in the field of virus detection. The research team suggests that with a commercial partner experienced in design and manufacturing, the LoCKAmp could be redesigned into a compact, portable device, ideal for use in areas with limited access to healthcare. Beyond just evaluating nasal swab samples, the LoCKAmp technology also has the potential for anonymous, community-level virus monitoring by testing samples from sources such as wastewater.

“This is an amazing display of the possibilities of lab-on-a-chip technology, and given the low cost and adaptability of the technology to detect a range of conditions, a potentially highly valuable and unique tool for a range of healthcare settings,” said Dr. Despina Moschou from the University of Bath who led the research.

Related Links:
University of Bath


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
COVID-19 Antigen Self-Test
Panbio COVID-19 Antigen Self-Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: A new study has identified patterns that predict ovarian cancer relapse (Photo courtesy of Cedars-Sinai)

Spatial Tissue Analysis Identifies Patterns Associated With Ovarian Cancer Relapse

High-grade serous ovarian carcinoma is the most lethal type of ovarian cancer, and it poses significant detection challenges. Typically, patients initially respond to surgery and chemotherapy, but the... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.